Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Deucravacitinib helped a man regrow hair and improve psoriasis.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Cetuximab can cause eyelash growth, which is rare but manageable.

A woman with severe angioedema improved significantly after treatment with rituximab.

The combination treatment showed a higher response rate but no significant survival benefits.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Axitinib treatment turned a man's grey hair back to black.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.